Ccmds/aml
Education · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
340 Rue Du Jasmin, La Prairie, Quebec, J...Phone Number
(778) 882-4389Website
www.ccmds.caRevenue
<$5 MillionIndustry
About Ccmds/aml
CCMDS organizes the Canadian Conference on Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML), collaborating with the Canadian Leukemia Study Group. The conference, scheduled for September 20-22, 2024, in Calgary, Alberta, aims to bring together international experts to discuss the latest developments in MDS and AML treatment. It targets healthcare professionals including hematologists, oncologists, and researchers involved in managing these conditions. The event also features opportunities for audience participation and supports educational initiatives for young investigators in the field.Explore more
SIC Code 79,799NAICS Code 61,611Show moreCcmds/aml Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Ccmds/aml
Compare insights from companies similar to Ccmds/aml, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ccmds/aml Tech Stack
A closer look at the technologies used by Ccmds/aml
See more technologies
Top Education Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ccmds/aml
Sign Up For FreeTo access detailed company insights
CCMDS organizes the Canadian Conference on Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML), collaborating with the Canadian Leukemia Study Group. The conference, scheduled for September 20-22, 2024, in Calgary, Alberta, aims to bring together international experts to discuss the latest developments in MDS and AML treatment. It targ... Read More
